Removing of the N-terminal methionine improves the sweetness of the recombinant expressed sweet-tasting protein brazzein and its mutants in Escherichia coli
The sweet-tasting protein brazzein is the smallest candy protein with excessive candy efficiency. Overexpression of this protein in a heterogenous host is a vital means for its manufacturing in meals trade. On this research, the gene of minor kind brazzein was cloned into the pET-SUMO vector with optimized codon utilization and expressed in E. coli BL21-CodonPlus (DE3)-RIL.
The recombinant protein in absence of the N-terminal methionine displayed a sweetness threshold about 1.5 μg/ml, which is the sweetest brazzein protein reported to date. The surprising candy efficiency of the protein was validated by a sequence of mutants (7Val → Arg, 9Glu → Lys and 9Glu → Asp), wherein E9K exhibited about 50% enhancement of sweetness than the wild sort. The superior sweetness of recombinant brazzein and its sweeter mutants counsel their potential purposes in meals and drinks.
PRACTICAL APPLICATIONS: The sweet-tasting proteins are pure, low-, or non-caloric and nutritive, exhibiting to be promising replacers of sugars and synthetic sweeteners, and can be utilized as candy components within the fields of meals, drugs, and biotechnology. Within the current research, we report that the recombinant brazzein protein expressed in E. coli reveals superior and improved sweetness than these beforehand reported.
Moreover, sweeter mutants had been obtained with the expression process. The superior sweetness of recombinant brazzein and its sweeter mutants counsel their potential purposes in meals, drinks, and different fields.
Key phrases: E. coli expression; N-terminus; mutant; sweet-tasting protein brazzein; sweetness
Recombinant Yeast AHA1 |
|||
| MBS806931-2x01mg | MyBiosource | 2x0.1mg | EUR 675 |
Recombinant Yeast AHA1 |
|||
| MBS806931-5x005mg | MyBiosource | 5x0.05mg | EUR 1260 |
Recombinant Yeast AHA1 |
|||
| MBS806931-5x01mg | MyBiosource | 5x0.1mg | EUR 1830 |
Yeast Hsp90 Co-chaperone AHA1 (AHA1) Protein |
|||
| abx675040-50g | Abbexa | 50 µg | EUR 437.5 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (HRP) |
|||
| MBS6181613-01mL | MyBiosource | 0.1(mL | EUR 875 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (HRP) |
|||
| MBS6181613-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (APC) |
|||
| MBS6168383-01mL | MyBiosource | 0.1(mL | EUR 875 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (APC) |
|||
| MBS6168383-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (PE) |
|||
| MBS6186023-01mL | MyBiosource | 0.1(mL | EUR 875 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (PE) |
|||
| MBS6186023-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (AP) |
|||
| MBS6163973-01mL | MyBiosource | 0.1(mL | EUR 875 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (AP) |
|||
| MBS6163973-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (FITC) |
|||
| MBS6177203-01mL | MyBiosource | 0.1(mL | EUR 875 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (FITC) |
|||
| MBS6177203-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (Biotin) |
|||
| MBS6172793-01mL | MyBiosource | 0.1(mL | EUR 875 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (Biotin) |
|||
| MBS6172793-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (MaxLight 750) |
|||
| MBS6237122-01mL | MyBiosource | 0.1(mL | EUR 875 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (MaxLight 750) |
|||
| MBS6237122-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (MaxLight 650) |
|||
| MBS6226447-01mL | MyBiosource | 0.1(mL | EUR 875 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (MaxLight 650) |
|||
| MBS6226447-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (MaxLight 490) |
|||
| MBS6205097-01mL | MyBiosource | 0.1(mL | EUR 875 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (MaxLight 490) |
|||
| MBS6205097-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (MaxLight 405) |
|||
| MBS6194422-01mL | MyBiosource | 0.1(mL | EUR 875 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (MaxLight 405) |
|||
| MBS6194422-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (MaxLight 550) |
|||
| MBS6215772-01mL | MyBiosource | 0.1(mL | EUR 875 |
AHSA1 (AHA1, Activator of Heat Shock 90kD Protein ATPase Homolog 1 (yeast), AHA1, C14orf3, p38) (MaxLight 550) |
|||
| MBS6215772-5x01mL | MyBiosource | 5x0.1mL | EUR 3800 |
Aha1, Active Human Recombinant Protein |
|||
| GWB-331CAB | GenWay Biotech | 200ug | Ask for price |
AHA1 (AHSA1) (NM_012111) Human Recombinant Protein |
|||
| E45H41225M5 | EnoGene | 20 ug | EUR 785.42 |
AHA1 (AHSA1) (NM_012111) Human Recombinant Protein |
|||
| PROTO95433 | BosterBio | Regular: 50ug | EUR 1249 |
|
Description: Recombinant protein of human AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast) (AHSA1) |
|||
Recombinant Yeast IDH1 Protein, Untagged, Yeast-50mg |
|||
| QP10670-50mg | EnQuireBio | 50mg | EUR 1251.6 |
Yeast TM Yeast Pst1 Recombinant Protein Liquid |
|||
| IYSTTMYSTPST1R50UG | Innovative research | each | EUR 344 |
|
Description: Yeast TM Yeast Pst1 Recombinant Protein Liquid |
|||
Yeast TM Yeast Pst1 Recombinant Protein Liquid |
|||
| MBS8434691-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Yeast IDH1 Protein, Untagged, Yeast-1mg |
|||
| QP10670-1mg | EnQuireBio | 1mg | EUR 186 |
Recombinant Yeast IDH1 Protein, Untagged, Yeast-5mg |
|||
| QP10670-5mg | EnQuireBio | 5mg | EUR 241.2 |
Yeast Yeast Kex-2 Recombinant Protein Lyophilized |
|||
| IYSTYSTKEX2RLY50UG | Innovative research | each | EUR 341 |
|
Description: Yeast Yeast Kex-2 Recombinant Protein Lyophilized |
|||
Yeast Yeast Kex-2 Recombinant Protein Lyophilized |
|||
| MBS8434692-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Saccharomyces Cerevisiae AHA1 Protein (aa 1-350) [His] |
|||
| VAng-Wyb4128-1mg | Creative Biolabs | 1 mg | EUR 5524.8 |
|
Description: Saccharomyces Cerevisiae (strain ATCC 204508 / S288c) Aha1p protein, recombinant protein. |
|||
Ahsa1 (GFP-tagged) - Mouse AHA1, activator of heat shock protein ATPase homolog 1 (yeast) (Ahsa1) |
|||
| MG205046 | Origene Technologies GmbH | 10 µg | Ask for price |
Ahsa1 (untagged) - Mouse AHA1, activator of heat shock protein ATPase homolog 1 (yeast) (Ahsa1), (10ug) |
|||
| MC201712 | Origene Technologies GmbH | 10 µg | Ask for price |
Ahsa2 (untagged) - Mouse AHA1, activator of heat shock protein ATPase homolog 2 (yeast) (Ahsa2), (10ug) |
|||
| MC214260 | Origene Technologies GmbH | 10 µg | Ask for price |
AHSA1 (untagged)-Human AHA1, activator of heat shock 90kDa protein ATPase homolog 1 (yeast) (AHSA1) |
|||
| SC115514 | Origene Technologies GmbH | 10 µg | Ask for price |
AHSA2 (untagged)-Human AHA1, activator of heat shock 90kDa protein ATPase homolog 2 (yeast) (AHSA2) |
|||
| SC101000 | Origene Technologies GmbH | 10 µg | Ask for price |
Recombinant Yeast GLRX1 Yeast Protein, His, E.coli-1mg |
|||
| QP11990-1mg | EnQuireBio | 1mg | EUR 1873.2 |
Recombinant Yeast GLRX2 Yeast Protein, His, E.coli-1mg |
|||
| QP11991-1mg | EnQuireBio | 1mg | EUR 1873.2 |
Recombinant Yeast GLRX1 Yeast Protein, His, E.coli-10ug |
|||
| QP11990-10ug | EnQuireBio | 10ug | EUR 186 |
Recombinant Yeast GLRX1 Yeast Protein, His, E.coli-50ug |
|||
| QP11990-50ug | EnQuireBio | 50ug | EUR 241.2 |
Recombinant Yeast GLRX2 Yeast Protein, His, E.coli-10ug |
|||
| QP11991-10ug | EnQuireBio | 10ug | EUR 186 |
Recombinant Yeast GLRX2 Yeast Protein, His, E.coli-50ug |
|||
| QP11991-50ug | EnQuireBio | 50ug | EUR 241.2 |
Recombinant Mouse AHA1 |
|||
| MBS7610818-005mg | MyBiosource | 0.05mg | EUR 470 |
Recombinant Mouse AHA1 |
|||
| MBS7610818-02mg | MyBiosource | 0.2mg | EUR 885 |
Recombinant Mouse AHA1 |
|||
| MBS7610818-1mg | MyBiosource | 1mg | EUR 2540 |
Recombinant Mouse AHA1 |
|||
| MBS7610818-5x1mg | MyBiosource | 5x1mg | EUR 9820 |
Recombinant Human AHA1 |
|||
| MBS7609003-005mg | MyBiosource | 0.05mg | EUR 405 |
Recombinant Human AHA1 |
|||
| MBS7609003-02mg | MyBiosource | 0.2mg | EUR 760 |
Recombinant Human AHA1 |
|||
| MBS7609003-1mg | MyBiosource | 1mg | EUR 2175 |
Regenerative impact of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) after sequestrectomy of medication-related osteonecrosis of the jaw (MRONJ)
Aims: Past the unique software permitted by the U.S. Meals and Drug Administration, recombinant human bone morphogenetic protein-2 (rhBMP-2) is used for medication-related osteonecrosis of the jaw (MRONJ) remedy due to its bone transforming enhancement properties. The aim of the research was to analyze the bone formation impact of rhBMP-2/absorbable collagen sponge (ACS) in sufferers with MRONJ.
Supplies and strategies: On this retrospective cohort research, 26 feminine sufferers recognized with MRONJ and who underwent mandibular sequestrectomy at Ajou College Dental Hospital from 2010 to 2018 had been included. The experimental group was composed of 18 sufferers who acquired rhBMP-2/ACSafter sequestrectomy, whereas the management group was composed of Eight sufferers who didn’t obtain rhBMP-2/ACS after sequestrectomy. A complete dose of 0.5 mg of rhBMP-2 was used within the experimental group at a focus of 0.5 mg/mL.
Observe-up panoramic X-rays had been taken instantly after the surgical procedure and greater than 6 months after the surgical procedure. Utilizing these X-rays, a radiographic index of bone defect space was calculated utilizing the modified Ihan Hren technique, which measures radiographic density of the conventional bone and the defect web site.
Outcomes: This research means that rhBMP-2 contributes to new bone formation. The imply radiographic index instantly after surgical procedure and greater than 6 months after the surgical procedure for the experimental group was 68.4% and 79.8%, respectively. The imply radiographic index instantly after surgical procedure and greater than 6 months after the surgical procedure for the management group was 73.4% and 76.7%, respectively (Wilcoxon signed rank take a look at, P>0.05). The imply radiographic index elevated 11.4% within the experimental group and three.27% within the management group (Mann-Whitney U-test, P <0.05).
Conclusion: Based mostly on the outcomes, use of rhBMP-2/ACS on bone defect websites after sequestrectomy might be a profitable technique for remedy of MRONJ sufferers.
Key phrases: Bisphosphonate-associated osteonecrosis of the jaw; Osteomyelitis; Osteonecrosis; Recombinant human bone morphogenetic protein-2.
Utility of the Leishmania infantum 21 kDa recombinant protein for the event of an immunochromatographic take a look at
Background: Visceral leishmaniasis (VL), brought on by Leishmania infantum is a systemic parasitic illness and presents a worldwide well being downside which might be deadly if not recognized and handled. Canine are the primary hosts and supply reservoirs for the transmission of the illness to people.
Strategies: On this research, the gene encoding a 21 kDa protein was cloned and expressed as a fusion protein in Escherichia coli pressure BL21 (DE3) for creating a speedy immunochromatographic take a look at (ICT) to establish contaminated canine.
The expression of the recombinant 21 kDa protein (r21) was investigated utilizing SDS-PAGE and western blotstrategies. The purified r21 kDa protein was noticed onto ICT strips and examined by sera from experimentally contaminated, naturally contaminated, and uninfected canine.
Outcomes: The SDS-PAGE and western blot strategies confirmed the profitable expression of r21 kDa protein. The ICT strip take a look at revealed that the r21 kDa protein was detected by the sera of experimentally and naturally contaminated canine. The specificity assessments additionally confirmed no cross-reactivity with animals contaminated with Trypanosoma cruzi, Toxoplasma gondii, and Ehrlichia canis.
Conclusions: Based mostly on these findings the brand new r21 kDa protein could also be an acceptable goal for creating a brand new easy, particular and speedy serological technique to detect VL in contaminated canine.
Key phrases: Leishmania infantum; 21 kDa protein; Canine; Immunochromatographic take a look at; Visceral leishmaniasis.
Recombinant purified Human Alpha Synuclein mutant protein (61-140 aa) |
|||
| SYN-61140-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Recombinant purified Human Alpha Synuclein mutant protein (1-60 aa) |
|||
| SYN-160-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Recombinant purified Human Alpha Synuclein mutant protein (1-95 aa) |
|||
| SYN-195-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Recombinant purified Human Alpha Synuclein protein (140 aa full length, wild type) |
|||
| SYN11-R-50 | Alpha Diagnostics | 50 ug | EUR 343.2 |
Recombinant purified Human Alpha Synuclein mutant protein (Delta NAC/96-140 aa) |
|||
| SYN-96140-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Human Alpha Synuclein protein W. blot +ve control |
|||
| SYN11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Recombinant (E.Coli) purified Mouse Alpha Synuclein protein (140 aa full length, wild type) |
|||
| SYN12-R-20 | Alpha Diagnostics | 20 ug | EUR 489.6 |
Purified recombinant Human beta Synuclein protein W. blot +ve Control |
|||
| SYN13-C | Alpha Diagnostics | 100ul | EUR 343.2 |
Recombinant Purified Human beta Synuclein protein full length (1-134 aa) |
|||
| SYN-25-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Recombinant Purified Human Gamma Synuclein protein full length (1-127 aa) |
|||
| SYN-35-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Human Synuclein alpha Recombinant Protein |
|||
| 500-094 | ReliaTech | 500 µg | EUR 430.5 |
|
Description: Alpha-Synuclein is a member of the Synuclein family. It is expressed principally in brain but also expressed in low concentrations in all tissues except liver. Alpha synuclein interacts with UCHL1, Phospholipase D and histones. In addition, alpha synuclein is an important regulatory component of vesicular transport in neuronal cells. It has been suggested that alpha synuclein is related to the pathogenesis of Parkinson's Disease and neurodegenerative disorders. Defects in its action will lead to Dementia Lewy Body (DLB).Human Alpha-Synuclein, is also known as Non-A Beta Component of AD Amyloid, Non-A4 Component of Amyloid Precursor, NACP, SNCA, NACP, PARK1. Recombinant Human alpha-Synuclein is produced by our E.coli expression system and the target gene encoding Met1-Ala140 is expressed, and purified as periplasmic protein by ion-exchange chromatography. |
|||
Human Synuclein alpha Recombinant Protein |
|||
| 500-094S | ReliaTech | 100 µg | EUR 199.5 |
|
Description: Alpha-Synuclein is a member of the Synuclein family. It is expressed principally in brain but also expressed in low concentrations in all tissues except liver. Alpha synuclein interacts with UCHL1, Phospholipase D and histones. In addition, alpha synuclein is an important regulatory component of vesicular transport in neuronal cells. It has been suggested that alpha synuclein is related to the pathogenesis of Parkinson's Disease and neurodegenerative disorders. Defects in its action will lead to Dementia Lewy Body (DLB).Human Alpha-Synuclein, is also known as Non-A Beta Component of AD Amyloid, Non-A4 Component of Amyloid Precursor, NACP, SNCA, NACP, PARK1. Recombinant Human alpha-Synuclein is produced by our E.coli expression system and the target gene encoding Met1-Ala140 is expressed, and purified as periplasmic protein by ion-exchange chromatography. |
|||
SNCA Alpha Synuclein Human Recombinant Protein |
|||
| PROTP37840-8 | BosterBio | Regular: 100ug | EUR 380.4 |
|
Description: a-Synuclein Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain of 140 amino acids having a molecular mass of 14.4kDa (Real molecular weight on SDS-PAGE will be shift up). ;The Recombinant Human a-Synuclein is purified by proprietary chromatographic techniques. |
|||
SNCA Alpha Synuclein 61-140 Human Recombinant Protein |
|||
| PROTP37840-5 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: A-Synuclein 61-140 Human Recombinant which is a deletion mutant of the a-synuclein amino acids 61-140 , produced in E.Coli is a single, non-glycosylated polypeptide chain of 81 amino acids having a molecular mass of 8.4kDa (molecular size on SDS-PAGE will appear higher), with an additional Met attached at the N-terminus. The Recombinant Human a-Synuclein 61-140 is purified by proprietary chromatographic techniques. |
|||
SNCA Alpha Synuclein 96-140 Human Recombinant Protein |
|||
| PROTP37840-6 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: A-Synuclein 96-140 Human Recombinant which is a deletion mutant of the a-synuclein amino acids 96-140, produced in E.Coli is a single, non-glycosylated polypeptide chain of 46 amino acids having a molecular mass of 5.2kDa, with an additional Met attached at the N-terminus. The Recombinant Human a-Synuclein 96-140 is purified by proprietary chromatographic techniques. |
|||
alpha Synuclein (SNCA) (NM_000345) Human Recombinant Protein |
|||
| E45H37189M5 | EnoGene | 20 ug | EUR 785.42 |
alpha Synuclein (SNCA) (NM_000345) Human Recombinant Protein |
|||
| E45H32499E0 | EnoGene | 100 ug | EUR 1088.75 |
alpha Synuclein (SNCA) (NM_001146055) Human Recombinant Protein |
|||
| E45H33162M5 | EnoGene | 20 ug | EUR 785.42 |
alpha Synuclein (SNCA) (NM_001146054) Human Recombinant Protein |
|||
| E45H33163M5 | EnoGene | 20 ug | EUR 785.42 |
alpha Synuclein (SNCA) (NM_007308) Human Recombinant Protein |
|||
| E45H34445M5 | EnoGene | 20 ug | EUR 785.42 |
alpha Synuclein (SNCA) (NM_007308) Human Recombinant Protein |
|||
| PROTP37840 | BosterBio | 20ug | EUR 1249 |
|
Description: Recombinant protein of human synuclein, alpha (non A4 component of amyloid precursor) (SNCA), transcript variant NACP112 |
|||
SNCA 21916 Alpha Synuclein 1-60 Human Recombinant Protein |
|||
| PROTP37840-7 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: A-Synuclein 1-60 Human Recombinant which is a deletion mutant of the a-synuclein amino acids 1-60 and contains the N-terminal amphipathic domain, produced in E.Coli is a single, non-glycosylated polypeptide chain of 60 amino acids having a molecular mass of 6.1kDa. The Recombinant Human a-Synuclein 1-60 is purified by proprietary chromatographic techniques. |
|||
Recombinant Purified Mouse Gamma Synuclein protein full length |
|||
| SYN-36-R | Alpha Diagnostics | 50ug | EUR 315.6 |
SNCA Alpha Synuclein NACP112 Human Recombinant Protein |
|||
| PROTP37840-4 | BosterBio | Regular: 20ug | EUR 380.4 |
|
Description: A-Synuclein NACP112 Human Recombinant which is an alternatively spliced (103-129) form of a-Synuclein, produced in E.Coli is a single, non-glycosylated polypeptide chain of 112 amino acids having a molecular mass of 11.3kDa. The Recombinant Human a-Synuclein NACP112 is purified by proprietary chromatographic techniques. |
|||
Alpha Synuclein Human Recombinant |
|||
| rAP-4922 | Angio Proteomie | Inquiry | Ask for price |
recombinant human alpha synuclein |
|||
| E4A10L13 | EnoGene | 100ug | EUR 595 |
SNCA Alpha Synuclein Delta-NAC Human Recombinant Protein |
|||
| PROTP37840-3 | BosterBio | Regular: 50ug | EUR 380.4 |
|
Description: A-Synuclein Delta-NAC Human Recombinant which is a deletion mutant of the a-synuclein that lacks the NAC region (amino acid 61-95), produced in E.Coli is a single, non-glycosylated polypeptide chain of 111 amino acids having a molecular mass of 11.9kDa (molecular size on SDS-PAGE will appear higher), with 6 amino acids added as a linker. The Recombinant Human a-Synuclein Delta-NAC is purified by proprietary chromatographic techniques. |
|||
Alpha Synuclein 61-140 Human Recombinant |
|||
| rAP-4919 | Angio Proteomie | Inquiry | Ask for price |
Alpha Synuclein 96-140 Human Recombinant |
|||
| rAP-4920 | Angio Proteomie | Inquiry | Ask for price |
Active Human Recombinant A53T Mutant Alpha Synuclein Protein Monomer |
|||
| MBS8005531-01mg | MyBiosource | 0.1mg | EUR 490 |
Active Human Recombinant A53T Mutant Alpha Synuclein Protein Monomer |
|||
| MBS8005531-10x01mg | MyBiosource | 10x0.1mg | EUR 2940 |
Active Human Recombinant A53T Mutant Alpha Synuclein Protein Monomer |
|||
| MBS8005531-2x01mg | MyBiosource | 2x0.1mg | EUR 710 |
Active Human Recombinant A53T Mutant Alpha Synuclein Protein Monomer |
|||
| MBS8005531-5x01mg | MyBiosource | 5x0.1mg | EUR 1330 |
Recombinant Human Synuclein‑alpha/SNCA Protein, No Tag |
|||
| E40KMH1784 | EnoGene | 20ug | EUR 495 |
Recombinant Human Synuclein?alpha/SNCA protein, No Tag |
|||
| MBS1560950-005mg | MyBiosource | 0.05mg | EUR 320 |
Recombinant Human Synuclein?alpha/SNCA protein, No Tag |
|||
| MBS1560950-01mg | MyBiosource | 0.1mg | EUR 410 |
Recombinant Human Synuclein?alpha/SNCA protein, No Tag |
|||
| MBS1560950-5x01mg | MyBiosource | 5x0.1mg | EUR 1520 |
Alpha Synuclein 1-60 Human Recombinant |
|||
| rAP-4921 | Angio Proteomie | Inquiry | Ask for price |